Connect2treat ApS: Financial statements 2019
CVR: 39649772
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Connect2treat ApS (CVR 39649772) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -41,619 and a net result of DKK -52,846. Equity in the 2019 report amounted to DKK -12,836.
- Gross Profit
- DKK -41,619
- Profit/Loss
- DKK -52,846
- Equity
- DKK -12,836
- Total Assets
- DKK 51,154
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of December 2, 2019, Kristine Appel Uldall Pallesen is registered as adm. dir. of Connect2treat ApS.
As of December 2, 2019, Katrine Lund Horneman-Thielcke has stepped down as director of Connect2treat ApS.
As of October 7, 2019, Katrine Lund Horneman-Thielcke is registered as director of Connect2treat ApS.
As of October 7, 2019, Tobias Julius Emil Horneman-Thielcke has stepped down as director of Connect2treat ApS.
On September 20, 2019, the company changed its name from Connect2treat IVS to Connect2treat ApS.
Connect2treat ApS has published its interim report for the period June 18, 2018 – December 31, 2018.
On April 26, 2019, the company changed its name from Trialink IVS to Connect2treat IVS.
About Connect2treat ApS
Connect2treat ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2018. The company is registered under the industry Computerprogrammering. The company was previously named Connect2treat IVS and Trialink IVS. The management consists of Tobias Julius Emil Horneman-Thielcke. The company is owned by Steiermark Group Holding ApS and Horneman-Thielcke Holding ApS. In 2025, the company reported a gross profit of DKK -4,875 and a net result of DKK -4,918 compared with DKK -4,453 the year before. Equity in the 2025 report amounted to DKK -58,691.